Granules India revenue up 3% but profit falls 16%

Granules India reported Q1FY26 revenue of INR 12,101m, up 3% year-on-year, driven by North America. EBITDA fell 5% to INR 2,467m due to higher manpower costs and Senn Chemicals consolidation.

Profit dropped 16% to INR 1,126m due to exceptional items including litigation settlements. The company achieved 91 US FDA approvals and cleared USFDA audits at key facilities.